Pharma & Biotechnology
Pharma & Biotechnology
Advancing Discovery. Accelerating Development. Enabling Precision.
At GeneInsight, we collaborate with pharmaceutical and biotechnology companies to accelerate drug discovery and development through comprehensive multiomics solutions. By integrating cutting-edge sequencing technologies with AI-powered bioinformatics, we help you navigate biological complexity, identify novel therapeutic targets, and reduce time-to-market for promising treatments.

Target & Biomarker Discovery
Our advanced multiomics platform—powered by genomics, transcriptomics, proteomics, and epigenomics—helps uncover actionable targets and biomarkers. Our AI-enhanced analysis tools, combined with the expertise of our world-class scientists, ensure your data leads to meaningful outcomes.

Accelerated Antibody Development
Fast-track your antibody discovery pipeline with our high-throughput, single-cell sequencing-based solutions. From antigen identification to validated recombinant antibodies, our streamlined workflow reduces development time to as little as four months.

Global Real-World Data Access
As part of an expansive global research network, we offer access to diverse real-world evidence (RWE) across North America, Europe, Asia, Africa, and Latin America. This allows us to support more inclusive, population-specific precision medicine strategies and uncover globally relevant drug targets.
Real Solutions for Real-World Research Challenges
At GeneInsight, we specialize in multiomics strategies that help researchers investigate the biological complexity behind today’s most critical areas of science:


Oncology

Immunology

Neurology

Rare & Infectious Diseases
